Natalizumab reduced serum levels of neurofilament light chain in secondary progressive multiple sclerosis patients from the phase 3 ASCEND study

被引：0
|
作者：
Kapoor, R. [1 ]
Sellebjerg, F. [2 ]
Hartung, H. -P. [3 ]
Arnold, D. L. [4 ]
Freedman, M. S. [5 ]
Jeffery, D. [6 ]
Miller, A. [7 ]
Edwards, K. R. [8 ]
Singh, C. M. [9 ]
Chang, I. [9 ]
Ren, Z. [9 ]
Sangurdekar, D. [9 ]
Zhu, B. [9 ]
Sheikh, S. [9 ]
Mehta, D. [9 ]
Ho, P. -R. [9 ]
Campbell, N. [9 ]
Edwards, M. [9 ]
Fisher, E. [9 ]
Kieseier, B. C. [9 ]
Rudick, R. A. [9 ]
Plavina, T. [9 ]
机构：
[1] UCL Inst Neurol, London, England
[2] Univ Copenhagen, Danish Multiple Sclerosis Ctr, Rigshosp, Copenhagen, Denmark
[3] Heinrich Heine Univ, Med Fac, Dept Neurol, Dusseldorf, Germany
[4] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada
[5] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[6] Piedmont HealthCare, Mooresville, NC USA
[7] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[8] MS Ctr Northeastern New York, Latham, NY USA
[9] Biogen, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1740
引用
收藏
页码：988 / 988
页数：1
相关论文
共 50 条
  • [1] Natalizumab Reduces Serum Concentrations of Neurofilament Light Chain in Secondary Progressive Multiple Sclerosis Patients From the Phase 3 ASCEND Study
    Kapoor, Raju
    Sellebjerg, Finn
    Hartung, Hans-Peter
    Arnold, Douglas
    Freedman, Mark S.
    Jeffery, Douglas
    Miller, Aaron
    Edwards, Keith R.
    Singh, Carol M.
    Chang, Ih
    Ren, Zhang
    Sangurdekar, Dipen
    Zhu, Bing
    Mehta, Devangi
    Ho, Pei-Ran
    Campbell, Nolan
    Edwards, Michael
    Fisher, Elizabeth
    Kieseier, Bernd C.
    Rudick, Richard A.
    Plavina, Tatiana
    [J]. NEUROLOGY, 2019, 92 (15)
  • [2] Neurofilament Light Chain Serum Levels Mirror Age and Disability in Secondary Progressive Multiple Sclerosis
    Husseini, Leila
    Jung, Jakob
    Boess, Natalie
    Kruse, Niels
    Nessler, Stefan
    Stadelmann, Christine
    Metz, Imke
    Haupts, Michael
    Weber, Martin S.
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (05):
  • [3] Siponimod Reduces Neurofilament Light Chain Blood Levels in Secondary Progressive Multiple Sclerosis Patients
    Kuhle, Jens
    Kropshofer, Harald
    Barro, Christian
    Meinert, Rolf
    Haring, Dieter A.
    Leppert, David
    Tomic, Davorka
    Dahlke, Frank
    Kappos, Ludwig
    [J]. NEUROLOGY, 2018, 90
  • [4] Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
    Bjornevik, Kjetil
    Munger, Kassandra L.
    Cortese, Marianna
    Barro, Christian
    Healy, Brian C.
    Niebuhr, David W.
    Scher, Ann I.
    Kuhle, Jens
    Ascherio, Alberto
    [J]. JAMA NEUROLOGY, 2020, 77 (01) : 58 - 64
  • [5] Neurofilament light chain levels in blood are predictive of cognitive impairment in patients with secondary progressive multiple sclerosis
    Kuhle, J.
    Kropshofer, H.
    Barro, C.
    Meinert, R.
    Haring, D.
    Leppert, D.
    Dahlke, F.
    Tomic, D.
    Kappos, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 666 - 666
  • [6] Serum neurofilament light chain levels in progressive multiple sclerosis: preliminary results of a prospective longitudinal study
    Ferraro, D.
    Mariotto, S.
    Bedin, R.
    Vaccari, G.
    Vitetta, F.
    Bardi, E.
    Corni, M. G.
    Molinari, M. A.
    Ferrari, S.
    Meletti, S.
    Sola, P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 525 - 526
  • [7] Elevated neurofilament light chain levels in progressive multiple sclerosis effectively reduced by cladribine treatment
    Yildiz, O.
    Mao, Z.
    Adams, A.
    Dubuisson, N.
    Allen-Philbey, K.
    Giovannoni, G.
    Malaspina, A.
    Baker, D.
    Gnanapavan, S.
    Schmierer, K.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 949 - 949
  • [8] The Predictive Value of Neurofilament Light Chain Levels in Blood for Cognitive Impairment in Patients with Secondary Progressive Multiple Sclerosis
    Kuhle, Jens
    Kropshofer, Harald
    Barro, Christian
    Meinert, Rolf
    Haring, Dieter
    Leppert, David
    Dahlke, Frank
    Tomic, Davorka
    Kappos, Ludwig
    [J]. NEUROLOGY, 2019, 92 (15)
  • [9] Serum neurofilament light chain levels as multiple sclerosis biomarker
    Abd-ElHady, Mohamed E.
    Hashish, Ehab
    Yassine, Imane
    Anani, Maha
    Negm, Mohamed
    [J]. PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2024, 28 (02) : 28 - 32
  • [10] Serum neurofilament light chain levels correlate strongly with cognitive status in patients with relapsing and progressive multiple sclerosis
    Edwards, K.
    Kamath, A.
    O'Connor, J.
    Kamath, V.
    Whidden, C.
    Button, A.
    Button, J.
    Bruso, P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (08) : NP6 - NP8
12345